Preparation and biodistribution studies of a radiogallium-acetylacetonate bis (thiosemicarbazone) complex in tumor-bearing rodents

Iranian Journal of Pharmaceutical Research

Volumn 11, Issue 2, 2012, Pages 523-531

  Jalilian, Amir Reza ^a   Yousefnia, Hassan ^a   Shafaii, Kamaleddin ^a   Novinrouz, Aytak ^a   Rajamand, Amir Abbas ^a  

^a AGRICULTURAL MEDICAL AND INDUSTRIAL RESEARCH SCHOOL   (Iran)

Author keywords

Acetyl acetone bis thiosemicarbazonate; Biodistribution; Fibrosarcoma; Gallium 67

Indexed keywords

ACETYLACETONATE BIS(THIOSEMICARBAZONE) GA 67; THIOSEMICARBAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; DRUG STABILITY; DRUG TISSUE LEVEL; FIBROSARCOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOTOPE LABELING; MOUSE; NONHUMAN; PARTITION COEFFICIENT; RADIOACTIVITY; TISSUE DISTRIBUTION;

EID: 84862745102     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. th ed., John Wiley and Sons, New York (1996) 1447.
2. Govindan SV, Goldenberg DM, Elsamra SE, Griffths GL, Ong MW, Brechbiel J, Burton G and Mattes MJ. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: comparison of Auger electron emitters with beta-particle emitters. J. Nucl. Med. (2000) 41: 2089-2097.
3. Stoll HP, Hutchins GD, Winkle WL, Nguyen AT, Appledorn CR, Janzen I, Seifert H, Rube C, Schieffer H and March KL Advantages of short-lived positron-emitting radioisotopes for intracoronary radiation therapy with liquid-filled balloons to prevent restenosis. J. Nucl. Med. (2001) 42:1375.
4. Arion VB, Jakupec MB, Galanski M, Unfried P and Keppler BK. Synthesis, structure, spectroscopic and in-vitro antitumour studies of a novel gallium (III) complex with 2-acetylpyridine (4) N-dimethylthiosemicarbazone. J. Inorg. Biochem. (2002) 91: 298.
5. Kratz F, Nuber B, Weigt J and Keppler BK. Synthesis and characterization of potential antitumour and antiviral gallium (III) complexes of N-heterocycles. Polyhedron (1992) 11: 487-498.
6. Miller MC, Stineman CN, Vance JR, West DX and Hall IH. The cytotoxicity of copper(II) complexes of 2-acetyl-pyridyl-4N-substituted thiosemicarbazones. Anticancer Res. (1998) 18: 4131.
7. Tsang BW, Mathias CJ, Fanwick PE and Green MA. Structure-distribution relationships for metal-labeled myocardial imaging agents: comparison of a series of cationic gallium (III) complexes with hexadentate bis (salicylaldimine) ligands. J. Med. Chem. (1994) 37: 4400-4406.
8. Green MA, Mathias CJ, Neumann WL, Janik M and Deutsch EA. Potential gallium-68 tracers for imaging the heart with PET: evaluation of four gallium complexes with functionalized tripodal tris(salicylaldimine) ligands. J. Nucl. Med. (1993) 34: 228-233.
9. Tsang BW, Mathias CJ and Green MA. A gallium-68 radiopharmaceutical that is retained in myocardium: 68Ga[(4,6-MeO2sal)2BAPEN]+. J. Nucl. Med. (1993) 34: 1127-1131.
10. Coggin DK, Mathias CJ and Green MA. Investigation of [67Ga]dimethylgallium(III) acetylacetonate as a potential radiopharmaceutical. Nucl. Med. Biol. (1994) 21: 283-285.
11. Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H and Konishi JA. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential Yokoyama. J. Nucl. Med. (1997) 38:1155-1160.
12. Lewis JS, Sharp TL, Laforest R, Fujibayashi Y and Welch MJ. Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. J. Nucl. Med. (2001) 42: 655-661.
13. Cowley AR, Dilworth JR, Donnelly PS, Gee AD and Heslop JM. Acetylacetonate bis(thiosemicarbazone) complexes of copper and nickel: towards new copper radiopharmaceuticals. Datton Transaction (2004) 16:2404-2412.
14. Haghighi Moghadam F, Jalilian AR, Nemati A and Abedini M. Preparation and biodistribution studies of [67Ga]2-acetylpyridine 4,4-dimethyl thiosemicarbazone complex as a possible SPECT tracer for detection of malignancies. J. Radioanal. Nucl. Chem. (2007) 272: 115-121.
15. Jalilian AR, Mehdipour P, Akhlaghi M, Yousefnia H and Shafai K. Evaluation of a [67Ga]-thiosemicarbazone complex as tumor imaging agent. Sci. Pharm. (2009) 77: 343-354
16. th ed., John Wiley and Sons Inc, New York (1976) 601-603.
17. th ed., John Wiley and Sons Inc, New York (1976) 281-284.
18. Gingras BA, Suprunchuk T and Bayley CH. The preparation of some thiosemicarbazones and their copper complexes, Part III. Can. J. Chem. (1962) 40: 1053-1057.
19. Packard AB, Kronauge JF, Barbarics E, Kiani S and Treves ST. Synthesis and biodistribution of a lipophilic 64Cu-labeled monocationic Copper(II) complex. Nucl. Med. Biol. (2002) 29: 289-294.
20. DiGiovanni J, Rymer J, Slaga TJ and Boutwell BK. Anticarcinogenic and co-carcinogenic effects of benzo[e]pyrene and dibenz[a,c]anthracene on skin tumor initiation by polycyclic hydrocarbons. Carcinogenesis (1982) 3: 371-375.
21. Hunter DH, McRoberts C and Vittal JJ. Bisthiosemicarbazones of 2,4-pentanedione are pyrazolines. Can. J. Chem. (1998) 76: 522-524.
22. Davies SC, Durrant MC, Hughes DL, Pezeshk A and Richards RL. Coordination chemistry of a pyrazoline derived from 2,4-pentanedione Bis(4-methylthiosemicarbazone). Crystal structure of the pyrazoline and evidence for metal-mediated ring opening. J. Chem. Res. (2001) 3: 100-103.
23. 67Ga localization in malignant disease. Nucl. Med. Biol. (1996) 23: 745-751.